These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36301560)

  • 1. Medicare's National Coverage Determination for Aducanumab - A One-Off or a Pragmatic Path Forward?
    Dhruva SS; Ramachandran R; Ross JS
    N Engl J Med; 2022 Oct; 387(17):1539-1541. PubMed ID: 36301560
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicare Should Not Cover Aducanumab as a Treatment for Alzheimer's Disease.
    Moghavem N; Henderson VW; Greicius MD
    Ann Neurol; 2021 Sep; 90(3):331-333. PubMed ID: 34278596
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare Coverage of Aducanumab - Implications for State Budgets.
    Sachs RE; Bagley N
    N Engl J Med; 2021 Nov; 385(22):2019-2021. PubMed ID: 34797617
    [No Abstract]   [Full Text] [Related]  

  • 4. Will CMS Find Aducanumab Reasonable and Necessary for Alzheimer Disease After FDA Approval?
    Schulman KA; Greicius MD; Richman B
    JAMA; 2021 Aug; 326(5):383-384. PubMed ID: 34279572
    [No Abstract]   [Full Text] [Related]  

  • 5. Focus on locus: evolution of Medicare's local coverage policy.
    Foote SB
    Health Aff (Millwood); 2003; 22(4):137-46. PubMed ID: 12889761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent proposals to limit Medigap coverage and modify Medicare cost sharing.
    Linehan K
    Issue Brief George Wash Univ Natl Health Policy Forum; 2012 Feb; (845):1-19. PubMed ID: 22420066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs for macular degeneration, price discrimination, and Medicare’s responsibility not to overpay.
    Silver J
    JAMA; 2014 Jul; 312(1):23-4. PubMed ID: 24860863
    [No Abstract]   [Full Text] [Related]  

  • 8. Elimination of Medicare's waiting period for seriously disabled adults: impact on coverage and costs.
    Dale SB; Verdier JM
    Issue Brief (Commonw Fund); 2003 Jul; (660):1-12. PubMed ID: 12868457
    [No Abstract]   [Full Text] [Related]  

  • 9. Why Is Aducanumab Priced at $56,000 per Patient? Lessons for Drug-Pricing Reform.
    Robinson JC
    N Engl J Med; 2021 Nov; 385(22):2017-2019. PubMed ID: 34797614
    [No Abstract]   [Full Text] [Related]  

  • 10. The use, safety and cost of bariatric surgery before and after Medicare's national coverage decision.
    Flum DR; Kwon S; MacLeod K; Wang B; Alfonso-Cristancho R; Garrison LP; Sullivan SD;
    Ann Surg; 2011 Dec; 254(6):860-5. PubMed ID: 21975317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare's demonstration of expanded coverage for chiropractic services: limitations of the demonstration and an alternative direct cost estimate.
    Weeks WB; Whedon JM; Toler A; Goertz CM
    J Manipulative Physiol Ther; 2013 Oct; 36(8):468-81. PubMed ID: 23993755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare mental health coverage.
    Coviello A; Glaun K
    Issue Brief Cent Medicare Educ; 2003; 4(3):1-6. PubMed ID: 12723580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfairness to Patients With Alzheimer Disease in Medicare's Coverage of Antiamyloid Immunotherapy.
    Stern AM; Selkoe DJ
    JAMA Neurol; 2022 Oct; 79(10):962-963. PubMed ID: 35913706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dupilumab drug survival, treatment failures, and insurance approval at a tertiary care center in the United States.
    Khosravi H; Zhang S; Anderson AM; Ferris LK; Choudhary S; Patton T
    J Am Acad Dermatol; 2020 Apr; 82(4):1023-1024. PubMed ID: 31866263
    [No Abstract]   [Full Text] [Related]  

  • 15. Medigap coverage and Medicare spending: a second look.
    Lemieux J; Chovan T; Heath K
    Health Aff (Millwood); 2008; 27(2):469-77. PubMed ID: 18332504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential effects of raising Medicare's eligibility age.
    Waidmann TA
    Health Aff (Millwood); 1998; 17(2):156-64. PubMed ID: 9558794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare's private plans: a report card on Medicare Advantage.
    Gold M
    Health Aff (Millwood); 2009; 28(1):w41-54. PubMed ID: 19029152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare's new prescription drug coverage.
    Habib H
    Surviv News (Atlanta Ga); 2005; 16(5):5. PubMed ID: 16388534
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescription drug coverage for people with Medicare.
    Stein N
    Issue Brief Cent Medicare Educ; 2002; 3(9):1-8. PubMed ID: 12516561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolving the tug-of-war between Medicare's national and local coverage.
    Foote SB; Wholey D; Rockwood T; Halpern R
    Health Aff (Millwood); 2004; 23(4):108-23. PubMed ID: 15318571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.